Literature DB >> 19113928

Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo.

Qiping Zheng1, Bettina Keller, Guang Zhou, Dobrawa Napierala, Yuqing Chen, Bernhard Zabel, Andrew E Parker, Brendan Lee.   

Abstract

The type X collagen gene (Col10a1) is a specific molecular marker of hypertrophic chondrocytes during endochondral bone formation. Mutations in human COL10A1 and altered chondrocyte hypertrophy have been associated with multiple skeletal disorders. However, until recently, the cis-enhancer element that specifies Col10a1 expression in hypertrophic chondrocytes in vivo has remained unidentified. Previously, we and others have shown that the Col10a1 distal promoter (-4.4 to -3.8 kb) may harbor a critical enhancer that mediates its tissue specificity in transgenic mice studies. Here, we report further localization of the cis-enhancer element within this Col10a1 distal promoter by using a similar transgenic mouse approach. We identify a 150-bp Col10a1 promoter element (-4296 to -4147 bp) that is sufficient to direct its tissue-specific expression in vivo. In silico analysis identified several putative transcription factor binding sites including two potential activator protein-1 (AP-1) sites within its 5'- and 3'-ends (-4276 to -4243 and -4166 to -4152 bp), respectively. Interestingly, transgenic mice using a reporter construct deleted for these two AP-1 elements still showed tissue-specific reporter activity. EMSAs using oligonucleotide probes derived from this region and MCT cell nuclear extracts identified DNA/protein complexes that were enriched from cells stimulated to hypertrophy. Moreover, these elements mediated increased reporter activity on transfection into MCT cells. These data define a 90-bp cis-enhancer required for tissue-specific Col10a1 expression in vivo and putative DNA/protein complexes that contribute to the regulation of chondrocyte hypertrophy. This work will enable us to identify candidate transcription factors essential both for skeletal development and for the pathogenesis of skeletal disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19113928      PMCID: PMC2683646          DOI: 10.1359/jbmr.081249

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  52 in total

1.  Genome-wide identification of tissue-specific enhancers in the Ciona tadpole.

Authors:  Naoe Harafuji; David N Keys; Michael Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

2.  An enhancer complex confers both high-level and cell-specific expression of the human type X collagen gene.

Authors:  David Chambers; David A Young; Charles Howard; J Terrig Thomas; David S Boam; Michael E Grant; Gillian A Wallis; Raymond P Boot-Handford
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

3.  AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element.

Authors:  J Hess; D Porte; C Munz; P Angel
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

4.  Role of c-fos in the regulation of type X collagen gene expression by PTH and PTHrP: localization of a PTH/PTHrP-responsive region in the human COL10A1 enhancer.

Authors:  Silvia Riemer; Sonja Gebhard; Frank Beier; Ernst Pöschl; Klaus von der Mark
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

5.  Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation.

Authors:  Richard C D'Alonzo; Nagarajan Selvamurugan; Gerard Karsenty; Nicola C Partridge
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

6.  CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.

Authors:  G Zhou; Y Chen; L Zhou; K Thirunavukkarasu; J Hecht; D Chitayat; B D Gelb; S Pirinen; S A Berry; C R Greenberg; G Karsenty; B Lee
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

7.  Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development.

Authors:  U I Chung; E Schipani; A P McMahon; H M Kronenberg
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

8.  Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1.

Authors:  W Jochum; J P David; C Elliott; A Wutz; H Plenk; K Matsuo; E F Wagner
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

9.  Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.

Authors:  Sonja Gebhard; Takako Hattori; Eva Bauer; Britta Schlund; Michael R Bösl; Benoit de Crombrugghe; Klaus von der Mark
Journal:  Matrix Biol       Date:  2008-07-12       Impact factor: 11.583

10.  BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation.

Authors:  E Minina; H M Wenzel; C Kreschel; S Karp; W Gaffield; A P McMahon; A Vortkamp
Journal:  Development       Date:  2001-11       Impact factor: 6.868

View more
  18 in total

1.  Indian hedgehog signaling regulates transcription and expression of collagen type X via Runx2/Smads interactions.

Authors:  Katsuhiko Amano; Michael Densmore; Riko Nishimura; Beate Lanske
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

2.  Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes.

Authors:  Peter Dy; Weihuan Wang; Pallavi Bhattaram; Qiuqing Wang; Lai Wang; R Tracy Ballock; Véronique Lefebvre
Journal:  Dev Cell       Date:  2012-03-13       Impact factor: 12.270

3.  Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation.

Authors:  A S Landman; P S Danielian; J A Lees
Journal:  Oncogene       Date:  2012-11-12       Impact factor: 9.867

4.  Putative function of TAP63α during endochondral bone formation.

Authors:  Feifei Li; Yaojuan Lu; Ming Ding; Guojun Wu; Satrajit Sinha; Siying Wang; Qiping Zheng
Journal:  Gene       Date:  2012-01-05       Impact factor: 3.688

5.  Col10a1-Runx2 transgenic mice with delayed chondrocyte maturation are less susceptible to developing osteoarthritis.

Authors:  Yaojuan Lu; Ming Ding; Na Li; Qian Wang; Jun Li; Xin Li; Junxia Gu; Hee-Jeong Im; Guanghua Lei; Qiping Zheng
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

6.  AP-1 family members act with Sox9 to promote chondrocyte hypertrophy.

Authors:  Xinjun He; Shinsuke Ohba; Hironori Hojo; Andrew P McMahon
Journal:  Development       Date:  2016-07-28       Impact factor: 6.868

7.  Establishment of a bone-specific col10a1:GFP transgenic zebrafish.

Authors:  Yong-Il Kim; Suman Lee; Seung-Hyun Jung; Hyun-Taek Kim; Jung-Hwa Choi; Mi-Sun Lee; Kwan-Hee You; Sang-Yeob Yeo; Kyeong-Won Yoo; SeongAe Kwak; Joon No Lee; Raekil Park; Seong-Kyu Choe; Cheol-Hee Kim
Journal:  Mol Cells       Date:  2013-07-12       Impact factor: 5.034

8.  Distinct function of P63 isoforms during embryonic skeletal development.

Authors:  Yaojuan Lu; Sam Abbassi; Feifei Li; Ming Ding; Guojun Wu; Junxia Gu; Qiping Zheng
Journal:  Gene       Date:  2013-02-26       Impact factor: 3.688

9.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

10.  Targeted induction of endoplasmic reticulum stress induces cartilage pathology.

Authors:  M Helen Rajpar; Ben McDermott; Louise Kung; Rachel Eardley; Lynette Knowles; Mel Heeran; David J Thornton; Richard Wilson; John F Bateman; Richard Poulsom; Peter Arvan; Karl E Kadler; Michael D Briggs; Raymond P Boot-Handford
Journal:  PLoS Genet       Date:  2009-10-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.